Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine in Splanchnic Nerve Neurolysis for Cancer Pain
NCT05291364Completed
- Sponsor
- Minia University
- Start
- Sep 2020
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of dexmedetomidine in cancer pain, sponsored by Minia University. Primary endpoint: Visual Analogue Scale at 2 weeks. Started Sep 2020; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
cancer pain
Beyond the preview
Go deeper on NCT05291364.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05291364.